(CRGY) Crescent Energy - Ratings and Ratios
Crude Oil, Natural Gas, Natural Gas Liquids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.70% |
| Yield on Cost 5y | 3.41% |
| Yield CAGR 5y | -12.71% |
| Payout Consistency | 91.5% |
| Payout Ratio | 31.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 43.2% |
| Value at Risk 5%th | 69.5% |
| Relative Tail Risk | -2.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.56 |
| Alpha | -59.11 |
| CAGR/Max DD | -0.09 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.350 |
| Beta | 1.659 |
| Beta Downside | 2.552 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.95% |
| Mean DD | 21.67% |
| Median DD | 17.23% |
Description: CRGY Crescent Energy November 10, 2025
Crescent Energy Co. (NYSE:CRGY) is a U.S.-based exploration and production firm focused on crude oil, natural gas, and natural gas liquids, with operations concentrated in Texas and the Rocky Mountain region. Founded in 2011 and headquartered in Houston, the company trades as a common stock within the Oil & Gas Exploration & Production sub-industry.
As of the latest 2023 annual report, Crescent produced roughly 30 MMboe (million barrels of oil equivalent) and reported a cash-flow conversion rate of about 85%, reflecting strong operational efficiency. The firm’s earnings are highly sensitive to WTI crude price movements and to regional drilling cost inflation, which have historically driven its profit margins. Recent strategic moves include the acquisition of additional Bakken assets, positioning the company to benefit from the ongoing U.S. shale production rebound.
For a deeper quantitative dive and scenario analysis, you may find ValueRay’s detailed model on CRGY useful for extending your research.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (23.5m TTM) > 0 and > 6% of Revenue (6% = 215.4m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA -2.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.50% (prev -2.40%; Δ -2.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 1.69b > Net Income 23.5m (YES >=105%, WARN >=100%) |
| Net Debt (3.22b) to EBITDA (1.47b) ratio: 2.19 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.81 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (254.6m) change vs 12m ago 19.78% (target <= -2.0% for YES) |
| Gross Margin 82.41% (prev 81.08%; Δ 1.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 37.90% (prev 29.33%; Δ 8.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.97 (EBITDA TTM 1.47b / Interest Expense TTM 290.4m) >= 6 (WARN >= 3) |
Altman Z'' 0.10
| (A) -0.02 = (Total Current Assets 702.7m - Total Current Liabilities 864.2m) / Total Assets 9.69b |
| (B) 0.00 = Retained Earnings (Balance) 15.7m / Total Assets 9.69b |
| (C) 0.03 = EBIT TTM 281.5m / Avg Total Assets 9.47b |
| (D) 0.00 = Book Value of Equity 15.7m / Total Liabilities 5.22b |
| Total Rating: 0.10 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 42.86
| 1. Piotroski 4.50pt |
| 2. FCF Yield -4.57% |
| 3. FCF Margin -7.55% |
| 4. Debt/Equity 0.72 |
| 5. Debt/Ebitda 2.19 |
| 6. ROIC - WACC (= -3.58)% |
| 7. RoE 0.61% |
| 8. Rev. Trend 54.72% |
| 9. EPS Trend -61.25% |
What is the price of CRGY shares?
Over the past week, the price has changed by +1.45%, over one month by -9.95%, over three months by -5.85% and over the past year by -38.76%.
Is CRGY a buy, sell or hold?
- Strong Buy: 9
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CRGY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.1 | 67.2% |
| Analysts Target Price | 14.1 | 67.2% |
| ValueRay Target Price | 8.4 | -0.2% |
CRGY Fundamental Data Overview December 24, 2025
P/E Forward = 5.2165
P/S = 0.7537
P/B = 0.6053
Beta = 1.194
Revenue TTM = 3.59b USD
EBIT TTM = 281.5m USD
EBITDA TTM = 1.47b USD
Long Term Debt = 3.22b USD (from longTermDebt, last quarter)
Short Term Debt = 3.64m USD (from shortTermDebt, last quarter)
Debt = 3.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b USD (from netDebt column, last quarter)
Enterprise Value = 5.93b USD (2.71b + Debt 3.23b - CCE 3.53m)
Interest Coverage Ratio = 0.97 (Ebit TTM 281.5m / Interest Expense TTM 290.4m)
FCF Yield = -4.57% (FCF TTM -271.1m / Enterprise Value 5.93b)
FCF Margin = -7.55% (FCF TTM -271.1m / Revenue TTM 3.59b)
Net Margin = 0.66% (Net Income TTM 23.5m / Revenue TTM 3.59b)
Gross Margin = 82.41% ((Revenue TTM 3.59b - Cost of Revenue TTM 631.6m) / Revenue TTM)
Gross Margin QoQ = 81.11% (prev 82.17%)
Tobins Q-Ratio = 0.61 (Enterprise Value 5.93b / Total Assets 9.69b)
Interest Expense / Debt = 2.25% (Interest Expense 72.6m / Debt 3.23b)
Taxrate = 28.19% (-4.03m / -14.3m)
NOPAT = 202.1m (EBIT 281.5m * (1 - 28.19%))
Current Ratio = 0.81 (Total Current Assets 702.7m / Total Current Liabilities 864.2m)
Debt / Equity = 0.72 (Debt 3.23b / totalStockholderEquity, last quarter 4.47b)
Debt / EBITDA = 2.19 (Net Debt 3.22b / EBITDA 1.47b)
Debt / FCF = -11.89 (negative FCF - burning cash) (Net Debt 3.22b / FCF TTM -271.1m)
Total Stockholder Equity = 3.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.24% (Net Income 23.5m / Total Assets 9.69b)
RoE = 0.61% (Net Income TTM 23.5m / Total Stockholder Equity 3.84b)
RoCE = 3.99% (EBIT 281.5m / Capital Employed (Equity 3.84b + L.T.Debt 3.22b))
RoIC = 2.83% (NOPAT 202.1m / Invested Capital 7.15b)
WACC = 6.41% (E(2.71b)/V(5.93b) * Re(12.13%) + D(3.23b)/V(5.93b) * Rd(2.25%) * (1-Tc(0.28)))
Discount Rate = 12.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 43.72%
Fair Price DCF = unknown (Cash Flow -271.1m)
EPS Correlation: -61.25 | EPS CAGR: -29.11% | SUE: -1.07 | # QB: 0
Revenue Correlation: 54.72 | Revenue CAGR: 18.18% | SUE: -0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=-0.018 | Revisions Net=-1 | Analysts=9
EPS next Year (2026-12-31): EPS=1.45 | Chg30d=-0.011 | Revisions Net=-1 | Growth EPS=-16.4% | Growth Revenue=+27.9%
Additional Sources for CRGY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle